157 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Downtrend
Article Searches
GILD, NVO, ZYNE and NOG among notable after hour movers https://seekingalpha.com/news/3465165-gild-nvo-zyne-nog-among-notable-hour-movers?source=feed_news_all May 17, 2019 - Top Gainers: GILD +3.1%. NOG +3.2%. NBRV +2.7%. GOL +2.3%. NIO +1%.Top Losers: LTM -4.7%. SIGA -1.9%. NKTR -1.8%. NVO -1.7%. ZYNE -1.7%.
Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug http://www.zacks.com/stock/news/412433/pharma-stock-roundup-agn-nvo-report-q1-earnings-nvs-to-buy-takedas-eye-drug?cid=CS-ZC-FT-412433 May 10, 2019 - Allergan (AGN) and Novo Nordisk (NVO) announce Q1 results. Novartis buys rights to Takeda's dry eye disease drug, Xiidra.
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug https://www.fool.com/investing/2019/05/09/novo-nordisk-trots-along-waiting-for-its-next-gene.aspx?source=iedfolrf0000001 May 09, 2019 - Oral semaglutide is on its way.
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jørgensen on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4259913-novo-nordisk-s-nvo-ceo-lars-fruergaard-jorgensen-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 03, 2019 - Novo Nordisk A/S (NYSE:NVO) Q1 2019 Results Conference Call May 03, 2019 07:00 AM ET Company Participants Lars Fruergaard Jørgensen - CEO Karsten Munk Knudsen - CFO Mads Krogsgaard Thomsen - Chief Sci
Novo Nordisk A/S (NVO) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/03/novo-nordisk-as-nvo-q1-2019-earnings-call-transcri.aspx?source=iedfolrf0000001 May 03, 2019 - NVO earnings call for the period ending March 31, 2019.
What's in the Cards for AEterna (AEZS) This Earnings Season? http://www.zacks.com/stock/news/407877/whats-in-the-cards-for-aeterna-aezs-this-earnings-season?cid=CS-ZC-FT-407877 May 02, 2019 - AEterna (AEZS) may provide update on the path forward for Macrilen in Europe on the first-quarter earnings call.
Why Earnings Season Could Be Great for Novo Nordisk (NVO) http://www.zacks.com/stock/news/407395/why-earnings-season-could-be-great-for-novo-nordisk-nvo?cid=CS-ZC-FT-407395 May 02, 2019 - Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Allergan (AGN) Beat Earnings Estimates Again in Q1? http://www.zacks.com/stock/news/406700/can-allergan-agn-beat-earnings-estimates-again-in-q1?cid=CS-ZC-FT-406700 May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? http://www.zacks.com/stock/news/405507/whats-in-store-for-ani-pharmaceuticals-anip-q1-earnings?cid=CS-ZC-FT-405507 Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
What's in Store for BioSpecifics (BSTC) This Earnings Season? http://www.zacks.com/stock/news/405553/whats-in-store-for-biospecifics-bstc-this-earnings-season?cid=CS-ZC-FT-405553 Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.

Pages: 123456...16

Page 1>